Hypergranular promyelocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2000 |
Adult Acute Promyelocytic Leukemia with PML-RARA
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Hunger Vital Sign
|
phenotype |
|
Sign or Symptom
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Trisomy 22
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
15q24 Microdeletion
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Congenital Abnormality
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Neoplasms, Therapy-Associated
|
phenotype |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
47, XYY syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Infections, Arenavirus
|
group |
Infections
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hyperfibrinolysis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Treatment related secondary malignancy
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Fanconi-Bickel Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
15
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Disease due to Papilloma virus
|
group |
Infections
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Transformation to acute myeloid leukaemia
|
disease |
Neoplasms
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Metrorrhagia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
17
|
2
|
0.100 |
None |
|
0 |
|
|
|
Productive Cough
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Productive Cough, CTCAE
|
phenotype |
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
JC virus infection
|
disease |
Infections
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Oral cavity bleeding
|
phenotype |
|
Pathologic Function
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Diffuse alveolar hemorrhage
|
disease |
|
Disease or Syndrome
|
21
|
|
0.100 |
None |
|
0 |
|
|
|
Bone marrow hypercellularity
|
phenotype |
|
Finding
|
26
|
|
0.100 |
None |
|
0 |
|
|
|
Burning sensation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mycoplasma-Induced Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
30
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Drug-Induced Stevens Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
31
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Sarcoma, Myeloid
|
disease |
Neoplasms
|
Neoplastic Process
|
31
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hepatic Veno-Occlusive Disease
|
disease |
Digestive System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
37
|
2
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |